tiprankstipranks
pc:neu04

Neuron23

343 Oyster Point Blvd Suite 120 South San Francisco, California 94080, US
https://neuron23.com/
Neuron23 Inc. is a clinical-stage biotechnology company developing precision medicines for genetically defined neurological and immunological diseases. The company combines human genetics, drug discovery and biomarker platforms with machine learning and artificial intelligence to advance therapeutics for neurodegenerative, neuroinflammatory, and systemic autoimmune and inflammatory disorders.

Leadership & Board

Current Number of Employees27
Current LinkedIn Followers6,349

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$97M
Total Amount Raised$97M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$97M
Latest Funding Amount$97M
Latest Funding RoundSeries D
Latest Funding RoundSeries D
Post-Money Valuation
Post-Money Valuation

Employee Trend

Neuron23 had 27 employees as of May 18, 2026. The number of employees increased by 0 (0.00%) week-over-week.
27Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Neuron23 had 6,349 followers as of May 18, 2026. The number of followers increased by 10 (0.16%) week-over-week.
6,349Latest Followers Count
10(0.16%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jul 24, 2025
Series D
$96.50M

Related News and Analysis